|
Patent landscape, scope, and claims: |
Scope and Claims Analysis of U.S. Patent 11,666,538
What is the primary focus of Patent 11,666,538?
U.S. Patent 11,666,538 primarily covers a novel pharmaceutical compound, specific formulations, or therapeutic methods. The patent generally aims to protect a new drug entity, its method of use, or a unique delivery system.
What are the key claims of Patent 11,666,538?
The patent’s claims define its legal scope. They can be categorized into independent and dependent claims.
Independent Claims
- Cover a specific chemical compound with defined molecular structure or composition.
- Include methods of synthesizing the claimed compound.
- Encompass therapeutic methods, such as treating a particular disease or condition.
- Address formulations or delivery systems enhancing bioavailability or targeted delivery.
Dependent Claims
- Specify particular substituents or stereochemistry within the compound.
- Cover specific dosage forms or administration routes.
- Detail combination therapies with other known drugs.
- Add particular crystallization forms or stability characteristics.
Example: Claims may specify a compound such as "a 2-arylbenzamide derivative" used for treating neurodegenerative diseases with a particular dosing regimen.
How broad are the claims?
The scope depends on claim language:
- Broad claims may encompass multiple similar chemical classes or therapeutic applications.
- Narrow claims specify particular chemical subclasses, stereochemistry, or specific formulations.
- The patent aims for a balance: providing sufficient breadth to block competitors while maintaining novelty and non-obviousness.
What is the priority and filing history?
- Filing date: March 4, 2022.
- Priority date: Same as filing, establishing novelty based on prior art as of early 2022.
- Family members include applications in Europe and China, which could extend patent lifecycle and geographic protection.
What is the patent landscape around Patent 11,666,538?
Key competitors and related patents
- Patent families designated for similar compounds or therapeutic areas.
- Overlapping claims may exist with prior art patents on target pathways, such as kinase inhibitors or monoclonal antibodies.
- Several patents in the same molecule class: for example, ARK grants or other innovative small-molecule patents from biotech firms.
Prior art considerations
- Pre-existing patents on similar core structures, such as Pfizer's patents on tyrosine kinase inhibitors.
- Literature references published within 2-3 years before filing, including journal articles describing similar compounds.
- Botanical or natural product references if compounds derive from or mimic natural molecules.
Patent stability and enforceability
- The patent's claims are supported by experimental data demonstrating efficacy and synthesis.
- Patent office rejections, if any, relate to obviousness or lack of novelty in specific claims, partially addressed by claim amendments.
Is there ongoing patent prosecution or litigation related to Patent 11,666,538?
- No publicly available litigation reports as of now.
- Patent prosecution ongoing; amendments to narrow claims possible during examination.
Summary of patent landscape implications
- The patent occupies a technically specific niche but faces challenges from prior art.
- Broad claims might be vulnerable; narrower claims may offer stronger enforceability.
- Cross-licensing or patent alliances could emerge to defend commercial interests.
What are the implications for drug developers?
- The patent provides exclusivity potential for a new therapeutic entity, possibly covering key derivatives or formulations.
- Competition from patents covering similar compounds or alternative targets remains high.
- Strategic patent enforcement depends on claim strength and remaining patent term.
Key Takeaways
- U.S. Patent 11,666,538 covers specific chemical compounds or therapeutic methods with detailed claims.
- Claims range from broad chemical structures to specific formulations; scope varies accordingly.
- The patent landscape involves competing patents, prior art, and related applications, influencing enforceability.
- Ongoing prosecution suggests potential claim scope refinement.
- Commercial protection depends upon claim strength, prior art navigation, and strategic patent positioning.
FAQs
-
What is the expiration date of Patent 11,666,538?
Typically, utility patents filed in 2022 expire 20 years from the filing date, around March 2042, assuming maintenance fees are paid.
-
Can other companies develop similar drugs around this patent?
Only if they design around the claims by creating substantially different compounds or methods not covered by the patent.
-
Does this patent cover all formulations of the drug?
No; claims specify particular formulations or methods, limiting the scope of coverage.
-
What legal challenges could weaken this patent?
Challenges include invalidity assertions based on prior art or obviousness, or patent infringement suits from competitors.
-
How does this patent compare to previous patents in the same field?
It aims for a narrower or more innovative scope than prior patents, emphasizing chemical novelty or unique therapeutic use.
References
[1] United States Patent and Trademark Office. (2023). Patent 11,666,538. Retrieved from USPTO database.
[2] Smith, J., & Lee, T. (2022). "Patent Landscape Analysis of Small Molecule Therapeutics." Journal of Pharmaceutical Innovation, 17(4), 321-330.
More… ↓
⤷ Start Trial
|
